Enoxolone

Star1

DB13089InvestigationalSmall molecule

Enoxolone (glycyrrhetic acid) has been investigated for the basic science of Apparent Mineralocorticoid Excess (AME).

Formula / weight: C₃₀H₄₆O₄ · 470.694 g/mol (avg)
Also known as: Glycyrrhetic Acid

Resolves to

Compound

UNIIP540XA09DRCAS471-53-4ChEMBLCHEMBL230006ChEBI30853PubChem10114KEGGC02283

Clinical / RWD

RxNorm1311506ATCD03AX10

Structure

InChIKeyMPDGHEJMBKOTSU-YKLVYJNSSA-NSMILES[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O

Targets

P18031PTPN1

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

6Marketed productsAcross 3 countries and 3 labellers

1ATC codeIncluding every combination product, plus 7 drug categories

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Enoxolone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account